Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
15 avr. 2024 08h00 HE
|
Optimi Health Corp.
Optimi announces completion of three batches of its MDMA API manufactured from raw materials under the Company’s Precursor Licence.
Global Analytical Standards Market Forecast at $2.08 Billion by 2030, Dominated by Merck, Waters Corporation, and Agilent Technologies - Strict Quality Regulations Driving the Market
11 avr. 2024 11h24 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Analytical Standards Market Size, Share & Trends Analysis Report by Category (Organic Analytical Standards, In-organic Analytical...
Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs
10 avr. 2024 22h37 HE
|
Novotech
The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning
10 avr. 2024 22h33 HE
|
Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04 avr. 2024 08h11 HE
|
Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract
02 avr. 2024 07h30 HE
|
Optimi Health Corp.
Optimi receives Certificate Of Analysis for GMP Natural Psilocybin Extract. Company has also completed the in-house encapsulation of 5mg & 10mg psilocybin.
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
28 mars 2024 07h30 HE
|
Optimi Health Corp.
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
25 mars 2024 07h48 HE
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
Animal Biotechnology Market Report 2024-2029, Featuring Profiles of Zeus Biotech, Invetx, Ingenta Connect, Kingfisher Biotech, Animab, Boehringer Ingelheim, RSPCA, Santa Cruz Biotechnology and Pfizer
20 mars 2024 13h37 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Animal Biotechnology Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The animal biotechnology market...
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
20 mars 2024 10h20 HE
|
PharmAla Biotech
PharmAla Recieves Notice of Allowance of Patent on Novel MDMA-like Molecule with improved safety, therapeutic range